Latest News and Press Releases

- Successful End-of-Phase 2 Meeting with FDA Led to Alignment on Phase 3 Program Design for CLS-AX in Wet AMD - - CLS-AX Targets Commercially Attractive Product Profile with Three-to-Six Month...

ALPHARETTA, Ga., May 09, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to...

Dublin, May 07, 2025 (GLOBE NEWSWIRE) -- The "Gene Therapy in Ophthalmology Market - A Global and Regional Analysis: Focus on Indication, Vector Type, and Region - Analysis and Forecast, 2025-2035"...

ALPHARETTA, Ga., May 01, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the...

Dublin, April 21, 2025 (GLOBE NEWSWIRE) -- The "Retinitis Pigmentosa Treatment Market Report and Forecast 2024-2032" has been added to ResearchAndMarkets.com's offering.The retinitis pigmentosa...

Dublin, April 17, 2025 (GLOBE NEWSWIRE) -- The "Juvenile Macular Degeneration Market" report has been added to ResearchAndMarkets.com's offering.The juvenile macular degeneration market was valued...

Dublin, April 08, 2025 (GLOBE NEWSWIRE) -- The "Ophthalmology Market by Diseases (Age-Related Macular Degeneration, Cataract, Glaucoma), Product Type (Drugs, Equipment, Prescription Glasses &...

Dublin, April 08, 2025 (GLOBE NEWSWIRE) -- The "Nonmydriatic Handheld Fundus Cameras Market by Component (Hardware, Software), Application (Age-related Macular Degeneration Monitoring, Cataract...

- Successful End-of-Phase 2 Meeting with FDA Results in Alignment on Phase 3 Plans for CLS-AX in Wet AMD - - Asia-Pacific Partner’s New Drug Application for ARCATUS® (XIPERE®) for Uveitic Macular...

- Suprachoroidal Delivery Develops as Promising Mainstream Procedure for Treating Multiple Macular Diseases - - SCS Microinjector® Provides Targeted and Compartmentalized Delivery of Therapeutics...